Doctors prescribe Dupixent to treat chronic rhinosinusitis with nasal polyps. It’s used for adults and children ages 12 years and older when other treatments, such as nasal corticosteroids, have ...

Because nasal polyps can block the inside of your nasal cavity and cause worse symptoms as they grow, treatment will be important. But which treatment is best for you? RELATED: 7 Surprising Reasons ...

Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Patients with Coexisting Asthma in First-ever Presented Phase 4 ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Other possible causes include allergies, a deviated nasal septum, and nasal polyps. Symptoms of frontal sinusitis may include nasal discharge, a feeling of “heaviness” or pressure behind the ...

Dupixent also outperformed Xolair in improving such key signs and symptoms as nasal polyp size and sense of smell in CRSwNP, ... with other medicines for the maintenance treatment of chronic ...

Sanofi and Regeneron's fast-growing immunology drug Dupixent is on course for a third indication in Europe after being recommended for approval as a treatment for people with nasal polyps ...

Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated ...

The FDA has fast-tracked approval of the first-in-its-class nasal epinephrine (neffy). It’s a very welcome addition to our anaphylaxis treatment armamentarium, notes Dr Gary Stadtmauer.

2, 3 The trials assessed the efficacy and safety of depemokimab as add-on therapy to standard of care in 271 and 257 adult patients with CRSwNP inadequately controlled on intranasal corticosteroids. 2 ...

A popular nasal decongestant ingredient was found ineffective ... nasal polyps; or irritants in your environment. Some medications, such as sedatives ... Children under 6 years old should not take ...